Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GR0I
|
|||
| Former ID |
DIB008553
|
|||
| Drug Name |
CD19-targeted allogeneic T-cell therapy
|
|||
| Synonyms |
CD19-targeted allogeneic T-cell therapy (acute lymphoblastic leukemia)
Click to Show/Hide
|
|||
| Indication | Acute lymphoblastic leukaemia [ICD-11: 2A85; ICD-10: C85.1, C88.7] | Phase 2 | [1] | |
| Company |
Baylor College of Medicine
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015 Jun 25;125(26):4017-23. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.